A Study of KM602 in Patients With Advanced Solid Tumors
Clinical trial NCT05766527 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05766527
- Sponsor
- Xuanzhu Biopharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2025-12-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.